# DoD Funds MediWound NexoBrid Development

The U.S. Department of Defense has awarded MediWound an additional **$3.3 million** to advance the development of a room-temperature stable formulation of its FDA-approved burn treatment, NexoBrid. This funding increases total government support for this program to **$21.8 million** and complements a broader **up to $197 million** BARDA contract held by MediWound's North American partner, Vericel, awarded in April 2026. The initiative aims to enhance the deployability and usability of NexoBrid in field and emergency settings, supporting military medical readiness and emergency response capabilities.

- **Why this matters:** The funding signals continued DoD and BARDA investment in advanced medical countermeasures for burn treatment, emphasizing the importance of stable, field-ready formulations.
- Contractors specializing in medical manufacturing, logistics, and emergency preparedness should evaluate opportunities related to production scale-up and supply chain support for NexoBrid.
- The potential establishment of a U.S.-based manufacturing facility under the BARDA contract may open additional procurement and subcontracting opportunities.
- Procurement professionals should note the strategic focus on enhancing military medical capabilities through innovative biotech solutions, which may influence future contract solicitations and funding priorities.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Grants & Funding
**Published:** September 24, 2026

### Government Entities
- U.S. Department of Defense (DoD)
- Biomedical Advanced Research and Development Authority (BARDA)
- Israel Defense Forces (IDF)

### Vendors
- MediWound (manufacturer)
- Vericel (North American commercial partner)

### Sources
- [$MDWD just banked another $3.3 million from the U.S. military — bringing total government funding for MediWound's room-temperature NexoBrid program to $21.8 million.

https://t.co/wDCxKyEj4F

Most biotech small-caps are chasing grants for things that do not yet exist. MediWound i](https://x.com/TheCapitalJunky/status/2103141490734027124) - twitter-fed-procurement